Status | Study |
Recruiting |
Study Name: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma Condition: Rhabdomyosarcoma Rhabdomyosarcoma- Alveolar Date: 2017-02-02 Interventions: Drug: Dasatinib Once daily on |
Recruiting |
Study Name: A Two-Part Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma Condition: Relapsed or Refractory Medulloblastoma (MB) (Part A: Also Include Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS)) Date: 2016-04-08 Interventions: Drug: TB-403 20mg/kg Up to 12 |
Suspended |
Study Name: Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma Condition: Alveolar Rhabdomyosarcoma Botryoid-Type Embryonal Rhabdomyosarc Date: 2015-10-02 Interventions: Drug: Cyclophosphamide Given I |
Completed |
Study Name: Biomarkers in Patients With Advanced Rhabdomyosarcoma Condition: Adult Rhabdomyosarcoma Childhood Alveolar Rhabdomyosarcoma Date: 2012-08-15 Interventions: Other: Laboratory Biomarker Analysis Correlative studies |
Completed |
Study Name: Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma Condition: Alveolar Childhood Rhabdomyosarcoma Embryonal Childhood Rhabdomyosarcoma Date: 2012-05-30 Interventions: Other: laboratory biomarker analysis Correlative studies |
Recruiting |
Study Name: CREATE: Cross-tumoral Phase 2 With Crizotinib Condition: Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma Locally Advanced and/or Me Date: 2012-01-24 Interventions: Drug: Crizotinib (PF-02341066) For patients of 15yo and older, Capsules of 200 and 250 mg Daily dose of |
Completed |
Study Name: Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Condition: Adult Rhabdomyosarcoma Childhood Alveolar Rhabdomyosarcoma Date: 2010-10-15 Interventions: Biological: Bevacizumab Given |
Completed |
Study Name: Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Condition: Adult Rhabdomyosarcoma Childhood Alveolar Rhabdomyosarcoma Date: 2010-01-22 Interventions: Biological: Cixutumumab Given |
Active, not recruiting |
Study Name: Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma Condition: Neuroblastoma Sarcoma Rhabdomyosarcoma-Embryonal Date: 2009-06-17 Interventions: Drug: Tumor Purged/CD25 Depleted Lymphocytes |
Active, not recruiting |
Study Name: Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Condition: Adult Malignant Mesenchymoma Adult Rhabdomyosarcoma Childh Date: 2006-07-19 Interventions: Drug: Irinotecan Hydrochloride |